Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1538 of 5804
-
New antibiotic flush could beat stubborn joint infections
Disease control CompletedStudy Type: A multi-site, parallel group, randomized trial. Study Objectives: The objective is to evaluate safety and determine preliminary efficacy of VT-X7 (Vancomycin and Tobramycin Exchanged over 7 Days). Efficacy is evaluated as superiority of the Experimental Arm in a comp…
Phase: PHASE2 • Sponsor: Osteal Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a buddy and a phone app help people with HIV stay healthy?
Disease control CompletedThis study called "Peers plus mobile App for Treatment in HIV (PATH)" is a two-arm randomized controlled trial (RCT) evaluating the efficacy of an intervention that combines peer navigation and mobile health (mHealth) technology to support HIV care outcomes among Hispanic and Bla…
Phase: NA • Sponsor: San Diego State University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Gut bacteria booster may help kidney cancer drugs work better
Disease control OngoingThis phase I trial evaluates the effects of CBM588 in combination with standard therapies, nivolumab and cabozantinib, in treating patients with kidney cancer that has spread to other places in the body (advanced/metastatic). The digestive microbiome may have an effect on how pat…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Heart surgery oxygen trick may keep patients off ventilators
Disease control CompletedThe iCAN trial is a pragmatic randomized controlled trial that aims to test the hypothesis that HFNC versus usual care oxygenation strategies applied immediately after initial extubation after cardiac surgery decreases the all-cause 48-hour reintubation rate (extubation failure w…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Could antidepressants finally silence chronic cough?
Symptom relief Recruiting nowThis research study is evaluating the effectiveness of escalating doses of Amitriptyline and Duloxetine in reducing cough frequency in patients with refractory chronic cough (RCC)
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Botox shots to the penis may help men last longer in bed
Symptom relief CompletedPremature ejaculation is a common sexual condition that can cause distress for men and their partners. Different treatments are available, but some men do not respond well to standard therapies. This study was designed to evaluate whether injecting botulinum toxin type A into tw…
Phase: NA • Sponsor: Al Mouwasat Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Bet $30 to quit smoking? this game could help you win money and beat the habit
Disease control CompletedThis study is a randomized controlled trial (RCT) of QuitBet, a digital contingency management program for smoking cessation. QuitBet combines social gaming elements with participant-funded financial incentives in the form of a deposit contract. QuitBet "players" deposit (called …
Phase: NA • Sponsor: WayBetter, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Virtual reality may offer Drug-Free pain relief for jaw disorder sufferers
Symptom relief OngoingThis project examines, in chronic pain, the mechanisms of immersive virtual reality compared to the mechanisms of placebo hypoalgesia. The potential of developing new non-pharmacological premises for low-risk interventions for pain management is high.
Phase: PHASE1, PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Massive cancer gene mapping project aims to unlock new treatments
Knowledge-focused Recruiting nowThe purpose of this study is to characterize the breadth of molecular features present in participants receiving care within a large, integrated, community-based healthcare system. Through comprehensive genomic profiling, investigators aim to identify the underlying genomic drive…
Sponsor: Avera McKennan Hospital & University Health Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New hope for Hard-to-Treat cancers: first human trial launches
Disease control Recruiting nowCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. Head and Neck Squamous Cell Carcinoma (HNSCC) is a solid tumor, a …
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo may protect bones after spinal cord injury
Disease control OngoingThe objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.
Phase: PHASE4 • Sponsor: James J. Peters Veterans Affairs Medical Center • Aim: Disease control
Last updated Jun 26, 2026 18:42 UTC
-
Simple cuff trick may shield heart failure patients from kidney damage
Disease control Recruiting nowThis is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in in patients with congestive …
Phase: PHASE2, PHASE3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Real-World data reveals immunotherapy Combo's impact on esophageal cancer
Knowledge-focused CompletedThis study is a multi-center, non-interventional study. Clinicopathologic, treatment , outcome and efficacy data will be collected from medical records in metastatic esophageal squamous cell carcinoma (ESCC) patients.
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
New breast CT scan could cut unnecessary Call-Backs
Diagnosis OngoingUp to one thousand and twenty-eight (1028) patients from screening and diagnostic population will be enrolled and consented to participate in the study to create an enriched data set. These women will be enrolled from annual screening population and diagnostic workup population. …
Phase: NA • Sponsor: Koning Corporation • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
Yoga vs. nerve pain: could stretching replace pills for chemo side effects?
Symptom relief OngoingThe purpose of this study is to test whether yoga can reduce nerve pain caused by cancer treatment (chemotherapy-induced peripheral neuropathy, or CIPN). Participants will take one of three approaches: * Yoga classes * Educational sessions on the causes and impacts of CIPN, how …
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New pill cools hot flashes without hormones?
Symptom relief CompletedResearchers are looking for a better way to treat women who have hot flashes after women have been through the menopause. Hot flashes are caused by the hormonal changes that happen when a woman's body has been through the menopause. Menopause is when women stop having a menstrual…
Phase: PHASE3 • Sponsor: Bayer • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New drug ProAgio tested in patients with advanced cancers
Disease control CompletedThe study is a first-in-human, Phase I study to assess the safety of ProAgio in participants with advanced solid tumor malignancies including pancreatic cancer.
Phase: PHASE1 • Sponsor: ProDa BioTech, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New cancer drug CLN-619 enters human trials for advanced tumors
Disease control OngoingCLN-619-001 is a Phase 1, open-label, multi-center study of CLN-619 alone and in combination with pembrolizumab in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Cullinan Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New combo shows promise for myeloma patients who failed earlier therapy
Disease control OngoingThis is a single-center, non-randomized, phase 2 study in which patients will receive daratumumab (subcutaneous, SC) in combination with clarithromycin/pomalidomide/dexamethasone (D-ClaPd) until progressive disease (PD) or unacceptable toxicity. This study will test the hypothesi…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug AOC 1001 tested for rare muscle disease
Disease control CompletedAOC 1001-CS1 is a randomized, double-blind, placebo-controlled, Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple-doses of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) patients (MARIN…
Phase: PHASE1, PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC